File:KEAP1 and NRF2 interacting with cellular metabolism.jpg
Size of this preview: 710 × 600 pixels. Other resolutions: 284 × 240 pixels | 568 × 480 pixels | 909 × 768 pixels | 1,212 × 1,024 pixels | 2,425 × 2,048 pixels | 3,200 × 2,703 pixels.
Original file (3,200 × 2,703 pixels, file size: 946 KB, MIME type: image/jpeg)
 | This is a file from the Wikimedia Commons. Information from its description page there is shown below. Commons is a freely licensed media file repository. You can help. |
 | This image was uploaded in the JPEG format even though it consists of non-photographic data. This information could be stored more efficiently or accurately in the PNG or SVG format. If possible, please upload a PNG or SVG version of this image without compression artifacts, derived from a non-JPEG source (or with existing artifacts removed). After doing so, please tag the JPEG version with {{Superseded|NewImage.ext}} and remove this tag. This tag should not be applied to photographs or scans. If this image is a diagram or other image suitable for vectorisation, please tag this image with {{Convert to SVG}} instead of {{BadJPEG}}. If not suitable for vectorisation, use {{Convert to PNG}}. For more information, see {{BadJPEG}}. |  |
Summary
| Description |
English: Figure 2 The interplay of the NRF2/KEAP1 pathway with cellular metabolism. NRF2 induces several metabolic pathways (red): Serine synthesis coupled to one-carbon metabolism can lead to NADPH regeneration, methyl group production, nucleotide synthesis, and the amino acids glycine and cysteine. The pentose phosphate pathway (PPP) regenerates NADPH and maintains nucleotide synthesis. Glutamine-derived glutamate along with glycine and cysteine form glutathione (GSH), the most abundant cellular antioxidant. Cysteine levels are maintained by cystine uptake in exchange for glutamate by the system xc− (xCT) antiporter, which consists of a heterodimer of SLC3A2 and SLC7A11, a bona fide NRF2 target. GSH and thioredoxin (TXN) scavenge reactive oxygen species (ROS) generated primarily from mitochondrial oxidative phosphorylation (OXPHOS) and form oxidized GSH (GSSG) and oxidized TXN, respectively. NADPH is essential for the reduction of both GSSG and oxidized TXN. Metabolic pathways that activate NRF2 (blue): Mitochondrial ROS, glycolysis-derived methylglyoxal, TCA (tricarboxylic acid) cycle–derived itaconate and fumarate, and polyunsaturated fatty acid alkenals can posttranslationally stabilize NRF2 (see Table 1). |
| Date | |
| Source | https://www.annualreviews.org/doi/full/10.1146/annurev-cancerbio-030518-055627 |
| Author | Warren L. Wu and Thales Papagiannakopoulos |
Licensing
This file is licensed under the Creative Commons Attribution 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 21:21, 12 September 2020 | | 3,200 × 2,703 (946 KB) | Elysia (AR) | Uploaded a work by Warren L. Wu and Thales Papagiannakopoulos from https://www.annualreviews.org/doi/full/10.1146/annurev-cancerbio-030518-055627 with UploadWizard |
File usage
The following page uses this file:
